Regulonix Holding, Inc.

About:

Regulonix is a biotechnology company that develops non-opioid drugs for chronic pain.

Website: http://www.regulonix.com

Top Investors: Desert Angels, UAVenture Capital

Description:

Regulonix is an early-stage biotechnology company developing non-opioid drugs for chronic pain. By indirectly targeting the sodium channel NaV1.7 – a well-established and genetically validated pain target – and focusing on the signaling pathways that control this channel’s activity, the Regulonix team has isolated compounds demonstrated in animal models to be non-addictive and more effective than morphine. This unique platform helps address a global pain management therapeutics market projected to reach $83B by 2024, affecting more than 100 million Americans and 1.5 billion people globally.